Status: open
Novartis (Exforge price-fixing)
Defendant: Novartis
Swiss pharmaceutical company Novartis has agreed to a $30 million settlement in a case alleging that the company engaged in a price-fixing scheme with company Par for the widely used blood pressure medication Exforge. If you purchased Exforge or a generic between Sept. 21, 2012, and June 30, 2018, and you live in one of 21 states (listed on the settlement website) or D.C., you may be eligible for payment.